Sung U. Kwon

Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.

Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.

Journal: The New England journal of medicine

Published: August 31, 2026

Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease.

Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease.

Journal: The New England journal of medicine

Published: March 30, 2026

Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial.

Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial.

Journal: Drug design, development and therapy

Published: December 12, 2025

The role of early ezetimibe combination with atorvastatin in patients with atherosclerotic cardiovascular disease.

The role of early ezetimibe combination with atorvastatin in patients with atherosclerotic cardiovascular disease.

Journal: BMC cardiovascular disorders

Published: November 20, 2025

The impact of diabetes on clinical outcomes in patients with pseudonormal left ventricular diastolic filling pattern and preserved ejection fraction.

The impact of diabetes on clinical outcomes in patients with pseudonormal left ventricular diastolic filling pattern and preserved ejection fraction.

Journal: Heart and vessels

Published: September 01, 2025

Combination of Fimasartan and Statins in Patients With Hypertension and Dyslipidemia.

Combination of Fimasartan and Statins in Patients With Hypertension and Dyslipidemia.

Journal: Journal of lipid and atherosclerosis

Published: August 06, 2025

Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study.

Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study.

Journal: Clinical therapeutics

Published: June 15, 2025

Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trial.

Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trial.

Journal: American heart journal

Published: February 18, 2025

Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial.

Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial.

Journal: Lipids

Published: December 18, 2024

Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study.

Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study.

Journal: Electrolyte & blood pressure : E & BP

Published: December 06, 2024

Comparison of Provisional 1-Stent Strategy With Drug-Eluting Balloon Versus Planned 2-Stent Strategy in Patients With Non-LM Coronary True-Bifurcation Lesions (PROVISION-DEB).

Comparison of Provisional 1-Stent Strategy With Drug-Eluting Balloon Versus Planned 2-Stent Strategy in Patients With Non-LM Coronary True-Bifurcation Lesions (PROVISION-DEB).

Journal: The American journal of cardiology

Published: November 21, 2024

Optimal Mechanical Circulatory Support Timing in Patients With Acute Myocardial Infarction With Cardiogenic Shock.

Optimal Mechanical Circulatory Support Timing in Patients With Acute Myocardial Infarction With Cardiogenic Shock.

Journal: JACC. Asia

Published: August 27, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026